Mexico IVD Market Analysis 2016-2021

Dublin, Sept. 08, 2017 -- The "Mexico IVD Market Analysis" report has been added to Research and Markets' offering.

The Mexican IVD market is considered moderate in its regulatory process and foreign investment opportunities. The health industry is witnessing strong growth with both imports and its growing medical export segments. Several domestic participants have acknowledged the participation in Mexico as a requirement for being a truly global business.

Mexico IVD Market Analysis is designed to provide the reader with an overview of the Mexican laboratory market and its influences.

The focus is on the IVD discipline including reagents, consumables, calibrators and controls of the following sub-segments:

• Clinical Chemistry
• Immunoassays
• Microbiology and Molecular Testing
• Point-of-Care Testing

The Mexican health sector is a mix of both private and public structures, with the private sector responsible for much of the laboratory business.

The burden of obesity, diabetes and cardiovascular disease are among the factors that have contributed to the current and future Mexico IVD market outlook as outlined in the report:

• Mexico IVD Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other, Histology, Other, Total)
• Mexico In Vitro Diagnostic Sales by Market Segment, 2016, Market Distribution (%) (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other, Histology, Other)
• Mexico Clinical Chemistry Market, 2016-2021
• Mexico Immunoassay Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
• Mexico Microbiology/Molecular Testing Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
• Mexico Point-of-Care (POC) Market Value by Segment, 2016 vs. 2021 (POC Glucose, POC Other)
• Mexico Histology Market, 2016-2021

Mexico IVD Market Analysis notes market drivers, which include an increasing interest in molecular testing technologies and point-of-care glucose testing. Included in the report are trends influencing the industry and country-level data including incidence of disease, life expectancy, population demographics, economic status, healthcare utilization and other market influences. The report also discusses market drivers and inhibitors for entering Mexico's medical device market.

In Mexico, the use of distributors is common with few IVD suppliers operating directly in the country.

The following global providers have very active Mexican subsidiaries/offices and are profiled in the report:

• Abbott Laboratories
• Becton, Dickinson And Company
• bioMrieux S.A.
• Danaher
• DiaSorin S.p.A.
• LifeScan, Inc.
• Roche (F. Hoffman-La Roche, Ltd.)
• Siemens Healthineers
• Sysmex Corporation
• Thermo Fisher Scientific

The information in Mexico IVD Market Analysis was gathered using both primary and secondary research methods, including more than 20 interviews completed during the period of April 2017 and July 2017. These interviews were with government officials, medical device regulators, Mexico-based distributors, health care providers and leading market participants. Secondary data included the use of government databases, company literature, medical journals, and reports.

Key Topics Covered:

1: Executive Summary

• Industry Overview
• Scope And Methodology
• Mexico IVD Market Summary
  • Figure 1-1: Mexico In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other, Histology, Other)

2: Mexico Overview

• Population
  • Table 2-1: Total Midyear Population by Broad Age Group: Mexico (million persons), 2010-2050 (0-14, 15-64, 65+, Total Population)
  • Figure 2-1: Total Midyear Population by Broad Age Group: Mexico (million persons), 2010-2050 (0-14, 15-64, 65+)
  • Figure 2-2: Total Number of Births in Mexico by Year, 1980-2010 and Forecast 2020-2050
  • Figure 2-3: Mexico Life Expectancy at Birth in Years, 2010-2050
• Population Urbanization
• Economy And Health Spending
  • Figure 2-4: Mexico GDP, GDP (PPP) and Health Spending, 1990-2015
  • Figure 2-5: Mexico Distribution of Income or Consumption by Quintile, 1990-2014 (Income share held by highest 20%, Income share held by fourth 20%, Income share held by third 20%, Income share held by second 20%, Income share held by lowest 20%)

3: The Health System In Mexico

• Health Infrastructure
  • Figure 3-1: Health Expenditures, Public vs. Private, as a % of Total Health Expenditures, 2015
• Medical Facilities
  • Figure 3-2: Distribution of JCI Accredited Facilities by Metropolitan Area (Culiacan, Tijuana, Cancun, Chihuahua, Mexico City)
  • Figure 3-3: Distribution of JCI Accredited Facilities by Type (%; Hospital Program, Ambulatory Care)
  • Figure 3-4: Distribution of JCI Accredited Facilities by Length of Time from First Accreditation (Withdrawn/Expired, 5+ Years, 2-5 Years, Less Than 2 Years)
  • Figure 3-5: Hospital Bed Density per 1,000 Population by Country,2016 Estimates (United States, UnitedKingdom, Singapore, Mexico, Japan, Germany, China, Canada, Brazil, Australia) Physicians and Health Professionals
  • Figure 3-6: Physician Density per 1,000 Population by Country, 2016 Estimates (United States, United Kingdom, Singapore, Mexico, Japan, Germany, China, Canada, Brazil, Australia)
  • Figure 3-7: Nurse/Midwife Density per 1,000 Population by Country, 2016 Estimates (United States,United Kingdom, Singapore, Mexico, Japan, Germany, China, Canada, Brazil, Australia)
• The Mexican Diagnostic Laboratory Environment
  • Figure 3-8: Laboratories and Collection Sites in Mexico by Type, 2016 (%; Commercial Laboratories,Collection Sites/Patient Service Centers)
  • Figure 3-9: Distribution of Volume, Mexico's Leading Clinical Laboratory Service Providers, 2016 (%) Medical Device Regulation
  • Table 3-1: Market Drivers and Inhibitors for Entering Mexico's Medical Device Market Mexico's Growing Medical Tourism Industry
• Health Indicators
• General Health
• Disease Profiles in Mexico
  • Table 3-2: Top 5 Cancers Affecting Mexican Population (ranked by total number of cases), 2010-2016
  • Figure 3-10: Medical Conditions/Diseases Prevalence in Mexico (Tuberculosis, Malaria, HIV, Diabetes,Dengue, Cardiovascular Diseases, Cancer)

4: IVD Markets In Mexico

• Mexico IVD Market Summary
  • Table 4-1: Mexico In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry,Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other, Histology, Other, Total)
  • Figure 4-1: Mexico In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC Glucose, POC Other, Histology, Other)
  • Figure 4-2: Mexico In Vitro Diagnostic Sales by Market Segment, 2016 Market Distribution (%) (Clinical Chemistry, Immunoassay Infectious Disease, Immunoassay Other, Microbiology/Molecular, POC GlucosePOC Other, Histology, Other)
• Clinical Chemistry
  • Figure 4-3: Mexico - Clinical Chemistry Market, 2016-2021
• Immunoassay
  • Table 4-2: Mexico - Immunoassay Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Immunoassay)
  • Figure 4-4: Mexico - Immunoassay Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
• Microbiology/Molecular
  • Table 4-3: Mexico - Microbiology/Molecular Testing Market Distribution, 2016-2021 (%) (Infectious Disease, Other, Total Microbiology/Molecular Testing)
  • Figure 4-5: Mexico Microbiology/Molecular Testing Market Value by Segment, 2016 vs. 2021 (Infectious Disease, Other)
• Point-Of-Care
  • Table 4-4: Mexico - POC Market Distribution, 2016-2021 (%) (POC Glucose, POC Other, Total POC)
  • Figure 4-6: Mexico POC Market Value by Segment, 2016 vs. 2021 (POC Glucose, POC Other)
• Histology
  • Figure 4-7: Mexico - Histology Market, 2016-2021

5: Competitive Analysis And Profiles

• Competitive Summary
  • Table 5-1: Leading IVD Market Suppliers in Mexico, Market Share Percentage, 2016
  • Figure 5-1: Leading IVD Market Suppliers in Mexico, 2016 (%)
• Abbott Laboratories
  • Table 5-2: Abbott Laboratories Company Summary
• Company Overview
• Company Performance
• Product Summary
• Becton, Dickinson And Company
  • Table 5-3: Becton, Dickinson and Company Summary
• Company Overview
• Company Performance
• Product Summary
• Biomrieux S.A.
  • Table 5-4: bioMerieux Summary
• Company Overview
• Company Performance
• Product Summary
• Danaher
  • Table 5-5: Danaher Summary
• Company Overview
• Company Performance
• Product Summary
• Diasorin S.P.A.
  • Table 5-6: DiaSorin S.p.A. Summary
• Company Overview
• Company Performance
• Product Summary
• Lifescan, Inc
  • Table 5-7: LifeScan Summary
• Company Overview
• Company Performance
• Product Summary
• Roche (F. Hoffman-La Roche, Ltd.)
  • Table 5-8: Roche Group Summary
• Company Overview
• Company Performance
• Product Summary
• Siemens Healthineers
  • Table 5-9: Siemens Healthineers Company Summary
• Company Overview
• Company Performance
• Product Summary
• Sysmex Corporation
  • Table 5-10: Sysmex Corporation Summary
• Company Overview
• Company Performance
• Product Summary
• Thermo Fisher Scientific
  • Table 5-11: Thermo Fisher Summary
• Company Overview
• Company Performance
• Product Summary
• Appendix: Sources Of Informationcr

For more information about this report visit https://www.researchandmarkets.com/research/7nxj28/mexico_ivd_market

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: In Vitro Diagnostics